BWAY

Companies
NASDAQ
Brainsway Ltd. ADR
Health Care
Price Chart
Overview

About BWAY

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Market Cap
$107.3M
Volume
383.9K
Avg. Volume
674.4K
P/E Ratio
86.437996
Dividend Yield
0.00%
Employees
133.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Medical Devices
Risk & Correlation Analysis
Market Correlation
0.93
Moderate Correlation
Volatility
High (0.56)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for BWAY.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, BWAY shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$107.3M
Volume383.9K
P/E Ratio86.44
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 11, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how BWAY fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025